• With fresh capital, Nabla accelerates its mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows
  
• Trusted by 130+ healthcare organizations and 85,000 clinicians, Nabla is expanding its AI assistant to support coding, agentic EHR commands, and a wider range of clinical roles, delivering measurable ROI across clinical workflows

NEW YORK, June 17, 2025 /PRNewswire/ — Nabla, one of the most widely adopted AI assistants in clinical care, today announced it has raised $70 million in Series C funding. Led by HV Capital, with Highland Europe joining as key investor, DST Global, and existing investors Cathay Innovation and Tony Fadell’s Build Collective, the funding brings Nabla’s total raise to $120 million. The new capital will accelerate product development, fuel growth across Nabla’s technical, clinical, and go-to-market teams, and support strategic partnerships to expand into new care settings and deliver impact at a national scale.

The round follows a wave of adoption across U.S. health systems, with Nabla’s AI assistant now embedded in more than 130 healthcare organizations, including major academic medical centers, safety-net hospitals, community health centers and physician groups nationwide. Now, Nabla is expanding beyond documentation into a more agentic model of clinical AI. This next phase enhances clinical documentation integrity (CDI), initiates EHR actions, and adapts across care settings to support diverse clinical roles. By unifying ambient listening, dictation, coding, and command capabilities into a single extensible agentic platform, Nabla is building toward its long-term vision: a proactive assistant that intuitively streamlines existing workflows.

“We’re going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties,” said Alex Lebrun, co-founder and CEO of Nabla. “Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery. We see a future where AI not only documents care, but actively drives efficiency by executing actions within complex clinical workflows and environments.”

Nabla’s assistant is now used by leading systems and providers, including CVS Health, Children’s Hospital Los Angeles, Carle Health, Denver Health, University of Iowa Health Care. Over the past year, adoption has surged across ambulatory, behavioral health, pediatric, and emergency settings, with early expansion into inpatient and nursing workflows underway. Nabla is helping clinicians cut documentation time by more than half: peer-reviewed studies from University of Iowa Health Care and real-world data from Denver Health confirm significant reductions in clinician burnout and a 15-point increase in patient satisfaction.

The company has multiplied its revenue by five over the past 6 months and now supports more than 85,000 clinicians and 20 million annual encounters. Designed to serve a broad range of care environments, Nabla’s assistant is available in 35 languages and is increasingly used in rural hospitals, FQHCs, and children’s hospitals, where clinician time is stretched and operational efficiency is mission-critical. The platform integrates with Epic, Cerner, athenahealth, NextGen, Greenway and other major EHRs and is built on a privacy-first model.

Nabla is also a member of the Coalition for Health AI, helping shape responsible AI governance in clinical care. At its core is a domain-specific large language model, refined over several years using clinically grounded data and a robust evaluation framework. This foundation enables advanced customization without compromising accuracy. Nabla now processes more than 30 billion tokens each month, a scale that supports continuous refinement and delivers measurable ROI for health systems.

With this new capital, Nabla will build a comprehensive Adaptive Agentic Platform, accelerating product development:

• Proactive Coding Agent: Improving existing real-time support for ICD-10, HCC, and MCC coding, with upcoming features to guide E/M coding and surface compliance nudges.
  
• Context-Aware Agent: Building on existing support for patient summaries and pre-charting, Nabla is expanding its use of historical data to introduce smarter documentation, initiate orders, and direct EHR commands through an intuitive interface.
  
• Custom Care Setting Agent: Deploying new capabilities tailored for nurses, with early expansion into inpatient environments and other frontline roles.

“Nabla stands out as a pioneer in clinical AI—not just for its bold vision, but for its enterprise-grade product and remarkable speed of execution,” said Alexander Joel-Carbonell, Partner at HV Capital. “What Alex, Delphine, and Martin have built is nothing short of extraordinary. I’ve rarely seen a technology scale this quickly, earn this level of trust, and deliver such exceptional accuracy. Today, more than 130 Tier 1 healthcare organizations rely on Nabla, a testament to the team’s ability to pair technological excellence with deep empathy for clinicians. It’s a privilege to support this exceptional team on their mission to transform healthcare.”

Nabla’s growth has been accompanied by a strong focus on clinician experience and enterprise readiness. The platform consistently outperforms alternatives in side-by-side pilots based on note quality, deployment speed, and overall clinician preference. Health system partners cite streamlined onboarding, high adoption rates, and strong alignment with clinical workflows. The company’s customer success model is built on responsiveness and rapid iteration, with health system partners citing hands-on support and real-time feedback loops as key drivers of adoption and sustained use.

“We’ve never seen a technology adopted like this across our organization. As an academic medical center, we serve a wide range of clinical needs. Nabla’s lightweight rollout made it easy for clinicians to start using it immediately,” said Dr. James Blum, Chief Health Information Officer and Associate Professor of Anesthesiology, University of Iowa Physicians. “It fits cleanly into Epic and supports how our clinicians deliver care. What stands out just as much as the speed of adoption is the partnership. Nabla listens, adapts, and builds with us. That kind of collaboration drives meaningful change, and we’re excited for what’s ahead.”

About Nabla
Nabla is on a mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows. Its assistant helps clinicians generate high-quality notes in seconds through ambient documentation, dictation, and real-time coding support. Nabla integrates with all major EHRs, supports more than 35 languages, and is used across over 130 health systems and provider groups.

The company is evolving into an adaptive agentic platform that supports a wider range of clinical workflows, care settings, and provider roles, empowering clinicians to dedicate more time to patient care.

Nabla was founded by Alex LeBrun (CEO), Delphine Groll (COO), and Martin Raison (CTO). Its leadership includes Dr. Ed Lee, Chief Medical Officer and former CIO of The Permanente Federation. Nabla’s advisors include Yann LeCun (Meta) and Tony Fadell (Build Collective). The company has raised $120 million from HV Capital, Highland Europe, Cathay Innovation, and others.

Learn more at www.nabla.com

Media Contact
nabla@hermespr.co

SOURCE Nabla

Copyright © 2025 Cision US Inc.